Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

BUY
$28.19 - $46.6 $2,819 - $4,660
100 New
100 $3,000
Q2 2021

Jul 19, 2021

SELL
$63.02 - $95.11 $33,967 - $51,264
-539 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$57.62 - $95.6 $28,810 - $47,800
500 Added 1282.05%
539 $36,000
Q4 2020

Jan 21, 2021

SELL
$41.43 - $77.09 $8,286 - $15,418
-200 Reduced 83.68%
39 $2,000
Q3 2020

Oct 27, 2020

SELL
$30.88 - $37.94 $11,147 - $13,696
-361 Reduced 60.17%
239 $9,000
Q2 2020

Jul 22, 2020

BUY
$18.95 - $35.43 $11,370 - $21,258
600 New
600 $21,000
Q4 2019

Feb 06, 2020

SELL
$19.24 - $28.41 $15,391 - $22,728
-800 Closed
0 $0
Q3 2019

Oct 28, 2019

SELL
$20.03 - $40.08 $12,018 - $24,048
-600 Reduced 42.86%
800 $18,000
Q1 2019

May 10, 2019

BUY
$22.09 - $39.21 $17,672 - $31,368
800 Added 133.33%
1,400 $44,000
Q3 2018

Nov 07, 2018

BUY
$12.1 - $28.85 $7,260 - $17,310
600 New
600 $17,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.25B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.